Teva Pharmaceuticals USA
Closed portfolio with an early-phase archive tilt
According to ClinicalTrials.gov-derived indexes, Teva Pharmaceuticals USA sits in the top decile of US sponsors by registered trial count (#271 of 15,742 sponsors by registered trial count).
Teva Pharmaceuticals USA: 83 sponsored US clinical trials, none currently recruiting.
Teva Pharmaceuticals USA sponsors 83 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 81 completed. 7 of these trials are in Phase 3-4 (later-stage) and 76 in Phase 1-2 (earlier-stage).
Top-decile sponsor footprint
Teva Pharmaceuticals USA ranks in the top decile of sponsors by registered trial count (#271 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
81 of 83 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (97.6%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Indexed trials (enrollment closed)
83 total, page 2 of 2
Ribavirin 200 mg Tablets Under Non-Fasting Conditions
NCT00835536
Cefprozil 500 mg Tablets Under Fed Conditions
NCT00840866
Divalproex Sodium Delayed-Release Tablets Under Fasting Conditions
NCT00834639
Ribavirin 200 mg Tablets Under Fasting Conditions
NCT00835146
Divalproex Sodium Delayed-Release Tablets Under Non-Fasting Conditions
NCT00834990
Lansoprazole 30 mg DR Capsule Replicate Food Study
NCT01046084
15 mg Mirtazapine Orally Disintegrating Tablets, Non-Fasting
NCT00834197
15 mg Mirtazapine Orally Disintegrating Tablets, Fasting
NCT00835575
Mesalamine 4 gm/60 mL Rectal Enema
NCT00840203
Glimepiride 4 mg Tablets Under Non-Fasting Conditions
NCT00835172
Glimepiride 4 mg Tablets Under Fasting Conditions
NCT00834340
Ondansetron HCl Orally Disintegrating Tablets Under Non-Fasting Conditions
NCT00934921
Ondansetron HCl Orally Disintegrating Tablets Under Fasting Conditions
NCT00934180
Clarithromycin 500 mg Tablets Under Fasting Conditions
NCT00835692
Clarithromycin 500 mg Tablets Under Non-Fasting Conditions
NCT00836706
Leflunomide 20 mg Tablets Under Fasting Conditions
NCT00834418
Finasteride 5 mg Tablets Under Fasting Conditions
NCT00835666
Finasteride 5 mg Tablets, Non-fasting
NCT00835796
Leflunomide 20 mg Tablets, Non-Fasting
NCT00834405
Zolpidem Tartrate 10 mg Tablets Under Non-Fasting Conditions
NCT00833937
Zolpidem Tartrate 10 mg Tablets Under Fasting Conditions
NCT00833521
Fexofenadine Hydrochloride 180 mg Tablets Under Non-Fasting Conditions
NCT00835640
Bioequivalence of Metronidazole Gel, 0.75% in the Treatment of Bacterial Vaginosis
NCT01020396
Terbinafine HCl 250 mg Tablet Under Fasting Conditions
NCT00833586
Buspirone Hydrochloride 30mg Tablets, Non-Fasting
NCT00840398
Buspirone Hydrochloride 30mg Tablets, Fasting
NCT00840606
Carvedilol (25 mg) in 24 Fed, Healthy, Adult Subjects
NCT00834873
Carvedilol 25 mg in 36 Fasted, Healthy, Adult Subjects
NCT00834795
Bioavailability of Metronidazole Vaginal Gel in Healthy Subjects
NCT01020877
90 mg Fluoxetine Hydrochloride Capsules Under Non-Fasting Conditions
NCT01247285
90 mg Fluoxetine Hydrochloride Capsules Under Fasting Conditions
NCT01247272
Benazepril HCl 40 mg Tablets, Fed
NCT00836537
Benazepril HCl 40 mg Tablets, Fasting
NCT00836576
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 76 |
| Phase 3 | 7 |
How the Teva Pharmaceuticals USA early-phase archive is shaped
83 indexed studies, none listed as recruiting (0% open); 81 completed (98%).
Phase mix: 7 late (III/IV) vs 76 early (I/II) (early-phase heavy).
Therapeutic area indexing for this sponsor is limited in the public registry.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Teva Pharmaceuticals USA: archived-pipeline peers nationwide
Peers matched on 83 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Teva Pharmaceuticals USA sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 83 archived trials
- Ferring Pharmaceuticals · 83 trials · 5% recruiting
- National Jewish Health · 83 trials · 8% recruiting
- New York University · 83 trials · 30% recruiting
- Seagen · 84 trials · 0% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this Teva Pharmaceuticals USA page
83 registered trials is a research-attention snapshot, not an endorsement of Teva Pharmaceuticals USA or any single study.
- None of Teva Pharmaceuticals USA's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Teva Pharmaceuticals USA pipeline card: 83 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.